245 related articles for article (PubMed ID: 16170750)
21. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
Ehlin-Henriksson B; Mowafi F; Klein G; Nilsson A
Immunology; 2006 Mar; 117(3):379-85. PubMed ID: 16476057
[TBL] [Abstract][Full Text] [Related]
22. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
[TBL] [Abstract][Full Text] [Related]
23. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
24. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction.
Yang L; Aozasa K; Oshimi K; Takada K
Cancer Res; 2004 Aug; 64(15):5332-7. PubMed ID: 15289339
[TBL] [Abstract][Full Text] [Related]
26. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
[TBL] [Abstract][Full Text] [Related]
27. B cells play a cooperative role via CD40L-CD40 interaction in T cell-mediated experimental autoimmune neuritis in Lewis rats.
Zhu W; Mix E; Jin T; Adem A; Zhu J
Neurobiol Dis; 2007 Mar; 25(3):642-8. PubMed ID: 17188497
[TBL] [Abstract][Full Text] [Related]
28. Hepatocellular apoptosis associated with cytotoxic T/natural killer-cell infiltration in chronic active EBV infection.
Nomura Y; Kimura H; Karube K; Yoshida S; Sugita Y; Niino D; Shimizu K; Kimura Y; Aoki R; Kiyasu J; Takeuchi M; Hashikawa K; Hirose S; Ohshima K
Pathol Int; 2009 Jul; 59(7):438-42. PubMed ID: 19563406
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection.
Zhang Y; Ohyashiki JH; Takaku T; Shimizu N; Ohyashiki K
Br J Cancer; 2006 Feb; 94(4):599-608. PubMed ID: 16449999
[TBL] [Abstract][Full Text] [Related]
30. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
[TBL] [Abstract][Full Text] [Related]
31. Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases.
Takahashi E; Asano N; Li C; Tanaka T; Shimada K; Shimada S; Yoshino T; Kojima M; Hara K; Eimoto T; Nakamura S
Histopathology; 2008 Apr; 52(5):585-96. PubMed ID: 18370955
[TBL] [Abstract][Full Text] [Related]
32. Effects of Epstein-Barr virus infection on the development of multiple myeloma after liver transplantation.
Zhang Y; Zhao H; He X; Zheng S; Wang T; Yan D; Sun J; Lu X; Wen J; Lau WY
Sci China Life Sci; 2012 Aug; 55(8):735-43. PubMed ID: 22932889
[TBL] [Abstract][Full Text] [Related]
33. EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.
Takada H; Imadome KI; Shibayama H; Yoshimori M; Wang L; Saitoh Y; Uota S; Yamaoka S; Koyama T; Shimizu N; Yamamoto K; Fujiwara S; Miura O; Arai A
PLoS One; 2017; 12(3):e0174136. PubMed ID: 28346502
[TBL] [Abstract][Full Text] [Related]
34. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-associated lymphoproliferative disorders.
Rezk SA; Weiss LM
Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
[TBL] [Abstract][Full Text] [Related]
36. Vascular lesion in a patient of chronic active Epstein-Barr virus infection with hypersensitivity to mosquito bites: vasculitis induced by mosquito bite with the infiltration of nonneoplastic Epstein-Barr virus-positive cells and subsequent development of natural killer/T-cell lymphoma with angiodestruction.
Kanno H; Onodera H; Endo M; Maeda F; Chida S; Akasaka T; Sawai T
Hum Pathol; 2005 Feb; 36(2):212-8. PubMed ID: 15754300
[TBL] [Abstract][Full Text] [Related]
37. The heat-shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation.
Jeon YK; Park CH; Kim KY; Li YC; Kim J; Kim YA; Paik JH; Park BK; Kim CW; Kim YN
J Pathol; 2007 Oct; 213(2):170-9. PubMed ID: 17768706
[TBL] [Abstract][Full Text] [Related]
38. [The clinical condition and diagnosis of EBV-T/NK-LPD (CAEBV, EBV-HLH etc.)].
Imadome K
Rinsho Ketsueki; 2013 Oct; 54(10):1992-8. PubMed ID: 24064853
[No Abstract] [Full Text] [Related]
39. Fatal natural killer cell lymphoma arising in a patient with a crop of Epstein-Barr virus-associated disorders.
Nitta Y; Iwatsuki K; Kimura H; Kojima S; Morishima T; Tsuji K; Oono T
Eur J Dermatol; 2005; 15(6):503-6. PubMed ID: 16280311
[TBL] [Abstract][Full Text] [Related]
40. Functional T-cell anergy in a case of persistent polyclonal B-cell lymphocytosis.
Mitterer M; Lanthaler AJ; Irschick EU; Engelmann H; Larcher C; Huemer HP
Leuk Res; 2005 Dec; 29(12):1479-88. PubMed ID: 15979703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
